1744 related articles for article (PubMed ID: 11527941)
1. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
2. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
Afonso AA; Sobrin L; Monroy DC; Selzer M; Lokeshwar B; Pflugfelder SC
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2506-12. PubMed ID: 10509643
[TBL] [Abstract][Full Text] [Related]
3. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
Yoon KC; Jeong IY; Park YG; Yang SY
Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
Narayanan S; Miller WL; McDermott AM
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
Brignole F; Pisella PJ; Goldschild M; De Saint Jean M; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers in the tears of patients with ocular surface disease.
Acera A; Rocha G; Vecino E; Lema I; Durán JA
Ophthalmic Res; 2008 Oct; 40(6):315-21. PubMed ID: 18688174
[TBL] [Abstract][Full Text] [Related]
9. Analysis of inflammatory cytokines in the tears of dry eye patients.
Massingale ML; Li X; Vallabhajosyula M; Chen D; Wei Y; Asbell PA
Cornea; 2009 Oct; 28(9):1023-7. PubMed ID: 19724208
[TBL] [Abstract][Full Text] [Related]
10. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
[TBL] [Abstract][Full Text] [Related]
11. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
[TBL] [Abstract][Full Text] [Related]
12. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.
Liu Z; Pflugfelder SC
Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393
[TBL] [Abstract][Full Text] [Related]
13. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
[TBL] [Abstract][Full Text] [Related]
14. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
[TBL] [Abstract][Full Text] [Related]
15. Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis.
El-Shabrawi YG; Christen WG; Foster SC
Curr Eye Res; 2000 Mar; 20(3):211-4. PubMed ID: 10694897
[TBL] [Abstract][Full Text] [Related]
16. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.
Goto E; Matsumoto Y; Kamoi M; Endo K; Ishida R; Dogru M; Kaido M; Kojima T; Tsubota K
Am J Ophthalmol; 2007 Jul; 144(1):81-85. PubMed ID: 17509507
[TBL] [Abstract][Full Text] [Related]
17. Elevated tear interleukin-6 levels in patients with Sjögren syndrome.
Tishler M; Yaron I; Geyer O; Shirazi I; Naftaliev E; Yaron M
Ophthalmology; 1998 Dec; 105(12):2327-9. PubMed ID: 9855167
[TBL] [Abstract][Full Text] [Related]
18. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
19. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.
Jain P; Li R; Lama T; Saragovi HU; Cumberlidge G; Meerovitch K
Exp Eye Res; 2011 Oct; 93(4):503-12. PubMed ID: 21726552
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival in vivo confocal scanning laser microscopy in patients with Sjögren syndrome.
Wakamatsu TH; Sato EA; Matsumoto Y; Ibrahim OM; Dogru M; Kaido M; Ishida R; Tsubota K
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):144-50. PubMed ID: 19696170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
